Skip to main content

and
Your search also matched 13 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Signes d’appel anténataux des maladies héréditaires du métabolisme

Include preview-only content
  1. Article

    Open Access

    Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)

    Mucopolysaccharidosis type I-Hurler syndrome (MPSI-H) is a lysosomal storage disease characterized by severe physical symptoms and cognitive decline. Early treatment with hematopoietic cell transplant (HSCT) i...

    N. Guffon, M. Pettazzoni, N. Pangaud, C. Garin in Orphanet Journal of Rare Diseases (2021)

  2. Article

    Open Access

    Clinical outcomes in a subpopulation of adults with Morquio A syndrome: results from a long-term extension study of elosulfase alfa

    This post hoc subanalysis examined outcomes in adult patients with Morquio A (mucopolysaccharidosis IVA) who received enzyme replacement therapy (ERT) with elosulfase alfa over a 120-weeks period. Patients ≥18...

    D. Hughes, R. Giugliani, N. Guffon, S. A. Jones in Orphanet Journal of Rare Diseases (2017)

  3. Article

    Open Access

    Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy

    Characteristic cardiac valve abnormalities and left ventricular hypertrophy are present in untreated patients with mucopolysaccharidosis type VI (MPS VI). Cardiac ultrasound was performed to investigate these ...

    E. Braunlin, H. Rosenfeld, C. Kampmann in Journal of Inherited Metabolic Disease (2013)

  4. Article

    Erratum to: Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters

    F. Hörster, S. F. Garbade, T. Zwickler in Journal of Inherited Metabolic Disease (2009)

  5. Article

    169 Update on Enzyme Replacement Therapy (ERT) with Recombinant Human Arylsulfatase B (RHASB) for MPS VI (Maroteaux-Lamy)

    MPS VI is a rare, life-threatening lysosomal storage disease with no effective treatment. ERT with rhASB has shown promising results in 2 clinical studies. The objective of this Phase 3 study was to confirm ef...

    P Harmatz, R Giugliani, I Schwartz, N Guffon, CSA Miranda, E Teles in Pediatric Research (2005)

  6. Article

    Outcome of 21 Children with Hurler Syndrome Transplanted from Related or Unrelated Donors

    G Souillet, N Guffon, I Maire, P Guibaud, N Philippe in Pediatric Research (1999)